Study identifies a link between antidepressant treatment resistance and inflammation

June 11, 2018, Emory University
Study identifies a link between antidepressant treatment resistance and inflammation
Levels of inflammation can be easily measured by simple blood tests, like C-reactive protein (CRP), readily available in clinics and hospitals throughout the U.S. Credit: Emory University

Researchers at Emory University have found that depressed patients who have not responded to multiple antidepressants exhibit evidence of increased inflammation. Findings were recently published online in the journal, Psychoneuroendocrinology.

The study shows that antidepressant treatment resistance is associated with increased inflammatory markers in with depression. One third of patients with depression fail to respond to currently available antidepressant medications.

Previous studies among laboratory animals have shown that inflammation has effects on the brain that can undermine the effectiveness of conventional antidepressants. This is one of the first studies in humans that confirms these findings.

"Our study suggests that measuring and targeting inflammation or its downstream effects on the brain may benefit patients with multiple failed antidepressant treatment trials during their current depressive episode," says senior author Andrew H. Miller, MD, William P. Timmie Professor of Psychiatry and Behavioral Sciences, Emory University School of Medicine.

Levels of inflammation can be easily measured by simple blood tests, like C-reactive protein (CRP), readily available in clinics and hospitals throughout the U.S.

Miller says if a patient's inflammation level is high (CRP>3mg/L), drugs that affect dopamine such as bupropion may be more effective for their depression than drugs that affect serotonin, the usual drugs prescribed.

"Patients who have tried and not responded to multiple antidepressants can ask their doctors if inflammation might be the cause. Ways to reduce inflammation include weight loss and exercise. Anti-inflammatory drugs are being tested for depression with some early promising results, but they are not approved for use at this time," says first author Ebrahim Haroon, MD, Assistant Professor of psychiatry and biomedical engineering at Emory University.

During the study, researchers measured blood concentrations of inflammatory molecules in 98 unmedicated patients with who had experienced varying numbers of failed antidepressant treatment trials in their current depressive episode.

Several molecules were associated with the number of failed treatment trials. For example, individuals failing two or three trials had significant elevations in the inflammatory cytokines tumor necrosis factor and its receptor as well as interleukin 6.

CRP was also higher in individuals with a greater number of failures, but only when obesity was not included in statistical analyses. Obesity is highly related to CRP.

Depression affects approximately 10 percent of the adult population in the United States and is the leading cause of disability worldwide.

Explore further: Level of inflammation could help predict effectiveness of electroconvulsive therapy for major depression

Related Stories

Level of inflammation could help predict effectiveness of electroconvulsive therapy for major depression

March 6, 2018
People with major depression that has not been well controlled by medications and who have a biomarker in their blood indicating a higher level of inflammation may benefit more than people with less inflammation from electroconvulsive ...

Inflammation markers could guide depression treatments

January 12, 2016
Psychiatrists investigating depression have been energized in recent years by reports of rapid, successful treatment with drugs that interfere with the brain chemical glutamate, such as the anesthetic ketamine.

Targeting inflammation to treat depression

September 3, 2012
Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of ...

IL-6 levels predict response to ECT in depressive disorder

March 14, 2018
(HealthDay)—For patients with major depressive disorder, interleukin-6 (IL-6) may predict benefit from electroconvulsive therapy (ECT), according to a study published recently in the Journal of Clinical Psychiatry.

Study links brain inflammation to suicidal thinking in depression

September 21, 2017
Patients with major depressive disorder (MDD) have increased brain levels of a marker of microglial activation, a sign of inflammation, according to a new study in Biological Psychiatry by researchers at the University of ...

Scientists reveal how inflammation affects the life of brain cells

October 10, 2017
New King's College London research reveals how blood inflammation affects the birth and death of brain cells, which could offer new treatment targets for antidepressants.

Recommended for you

When scientists push people to their tipping point

December 10, 2018
You probably overestimate just how far someone can push you before you reach your tipping point, new research suggests.

Early career choices appear to influence personality, study finds

December 10, 2018
In the state of Baden-Wurttemberg, Germany, 16-year-old students in middle-track schools decide whether to stay in school to pursue an academic career or enroll in a vocational training program. A new study offers evidence ...

Internet therapy apps reduce depression symptoms, study finds

December 7, 2018
In a sweeping new study, Indiana University psychologists have found that a series of self-guided, internet-based therapy platforms effectively reduce depression.

Gender bias sways how we perceive competence in faces

December 7, 2018
Faces that are seen as competent are also perceived as more masculine, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Targeted cognitive training benefits patients with severe schizophrenia

December 7, 2018
Schizophrenia is among the most difficult mental illnesses to treat, in part because it is characterized by a wide range of dysfunction, from hallucinations and mood disorders to cognitive impairment, especially verbal and ...

Pot withdrawal eased for dependent users

December 6, 2018
A new drug can help people diagnosed with cannabis use disorder reduce withdrawal symptoms and marijuana use, a new Yale-led study published Dec. 6 in the journal Lancet Psychiatry shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.